| Dr Michael A Janitch, MD | |
|
1715 Dousman St, Green Bay, WI 54303-3211 | |
| (920) 496-4700 | |
| (920) 405-1432 |
| Full Name | Dr Michael A Janitch |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 31 Years |
| Location | 1715 Dousman St, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366438798 | NPI | - | NPPES |
| 34084200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 42240020 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Mary's Hospital Medical Center | Green bay, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Hospital-hospital Sisters-third Order Of St Francis | 5799694675 | 562 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.
A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports
› Verified 4 days ago
| Entity Name | Prevea Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306869276 PECOS PAC ID: 0042123150 Enrollment ID: O20031106000034 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.
A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports
› Verified 4 days ago
| Entity Name | St Vincent Hospital-hospital Sisters-third Order Of St Francis |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285613638 PECOS PAC ID: 5799694675 Enrollment ID: O20080620000423 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.
A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael A Janitch, MD 2461 Holmgren Way, Green Bay, WI 54304-5224 Ph: (920) 496-4700 | Dr Michael A Janitch, MD 1715 Dousman St, Green Bay, WI 54303-3211 Ph: (920) 496-4700 |
News Archive
Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc. today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved NESINA (alogliptin) and the fixed-dose combination (FDC) therapies OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl) for the treatment of type 2 diabetes in adults as adjuncts to diet and exercise.
News outlets continue to report on the science discussed at the Conference on Retroviruses and Opportunistic Infections (CROI), which ended Friday in San Francisco.
In a study that included nearly 14,000 patients with rheumatoid arthritis or psoriasis, the use of certain disease-modifying antirheumatic drugs was found to lower the risk of diabetes, according to a study in the June 22/29 issue of JAMA.
A team of UK-based scientists has recently revealed that the alpha variant (B.1.1.7) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for the third pandemic wave in Scotland and that the variant is associated with more severe coronavirus disease 2019 (COVID-19). The study is currently available on the medRxiv* preprint server.
Clues that point toward new risk mechanisms for developing Parkinson's disease are hiding in some unusual spots, according to a study published today in Scientific Reports
› Verified 4 days ago
Edgar (ted) King Collison Iv, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1715 Dousman St, Green Bay, WI 54303 Phone: 920-496-4700 | |
Dr. Peter V Gapinski, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2845 Greenbrier Rd, #120, Green Bay, WI 54308 Phone: 920-288-8100 | |
Dr. Teresa A Gonzaga, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 Fax: 920-857-1488 | |
Benjamin Andrew, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1860 Shawano Ave, Green Bay, WI 54303 Phone: 920-496-4700 | |
Carrie Ann Thoms, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 1821 S Webster Ave, Green Bay, WI 54301 Phone: 920-496-4700 Fax: 920-436-1379 | |
Daniel Williams, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1726 Shawano Ave, Green Bay, WI 54303 Phone: 920-496-4700 | |
Karri Adamson, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Development Dr, Green Bay, WI 54311 Phone: 920-288-8240 |